Back
VanEck Natural Resources ETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
55
HAP
VanEck Natural Resources ETF
Last Price:
51.24
Seasonality Move:
1%
Buy
57
LBPH
Longboard Pharmaceuticals
Last Price:
33.93
Seasonality Move:
-17.05%
Buy
55
VanEck Natural Resources ETF (HAP)
is a Buy
Is VanEck Natural Resources ETF a Buy, Sell or Hold?
- The current VanEck Natural Resources ETF [HAP] share price is $51.32. The Score for HAP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- HAP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $33.89. The Score for LBPH is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HAP Stock Price Chart
What is VanEck Natural Resources ETF's stock price today?
-
The VanEck Natural Resources ETF share price today is $51.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HAP is experiencing selling pressure, which indicates risk of future bearish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $33.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
HAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 58.98 | Buy |
| Chaikin Money Flow: | -1735 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.73 - 51.29) | Buy |
| Bollinger Bands (100): | (49.61 - 51.85) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 50.99 | Buy |
| Chaikin Money Flow: | -590951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.08 - 36.28) | Sell |
| Bollinger Bands (100): | (21.09 - 35.99) | Buy |
HAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.61 | Buy |
| 20-day SMA: | 50.48 | Buy |
| 50-day SMA: | 50.3 | Buy |
| 200-day SMA: | 49.68 | Buy |
| 8-day EMA: | 50.8 | Buy |
| 20-day EMA: | 50.46 | Buy |
| 50-day EMA: | 50.37 | Buy |
| 200-day EMA: | 49.96 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.02 | Buy |
| 20-day SMA: | 33.9 | Sell |
| 50-day SMA: | 34.81 | Sell |
| 200-day SMA: | 23.39 | Buy |
| 8-day EMA: | 32.41 | Buy |
| 20-day EMA: | 33.31 | Buy |
| 50-day EMA: | 32.77 | Buy |
| 200-day EMA: | 24.23 | Buy |
VanEck Natural Resources ETF Earnings Growth & HAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
VanEck Natural Resources ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||